Tech Company Financing Transactions
Shifa Biomedical Funding Round
On 5/13/2021, Shifa Biomedical raised Seed funding from Xontogeny.
Transaction Overview
Company Name
Announced On
5/13/2021
Transaction Type
Venture Equity
Amount
Unknown
Round
Seed
Investors
Xontogeny (Chris Garabedian)
Proceeds Purpose
This seed investment will enable us to rapidly advance our drug product with efficient capital deployment and execute a successful development program.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
One Great Valley Pkwy. Great Valley Corporate Center 8
Malvern, PA 19355
USA
Malvern, PA 19355
USA
Phone
Website
Email Address
Overview
Shifa Biomedical Corporation (Shifa) is a drug discovery company in Malvern Pennsylvania. It is a privately held biopharmaceutical company dedicated to the cost-effective development of drugs for the treatment of cardiovascular disease.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
President
Sherin Abdel-Meguid
Vice President
Nabil Elshourbagy
Vice President
Harold Meyers
Browse more venture capital transactions:
Prev: 5/13/2021: Maptician venture capital transaction
Next: 5/13/2021: Cortex venture capital transaction
Share this article
About Our Venture Capital Transactions Database
Our team works diligently to report on every notable VC transaction. VC investment data records on this site are sourced from company press releases and news coverage. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs